Martin Shkreli's KaloBios files for bankruptcy

KaloBios Pharmaceuticals Inc. filed for Ch. 11 bankruptcy on Tuesday, according to information posted online by a U.S. bankruptcy court in Delaware. That filing comes as the drug company, which has been majority owned by controversial biotech investor Martin Shkreli, said Tuesday that it's been granted a February hearing on its appeal of the Nasdaq's decision to delist its shares. KaloBios Pharma's stock has been halted since Dec. 17, the day that Shkreli was arrested on fraud charges.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.